Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 3 Interventional

A 10-week Study Evaluating the Efficacy and Safety of PD 0332334 for the Treatment of Generalized Anxiety Disorder (3)

ClinicalTrials.gov ID: NCT00658762

Public ClinicalTrials.gov record NCT00658762. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 21, 2026, 5:17 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Randomized, Double-Blind, Parallel Group, 10-Week Placebo Controlled Fixed Dose Study of PD 0332334 and Paroxetine Evaluating the Efficacy and Safety of PD 0332334 for the Treatment of Generalized Anxiety Disorder

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a 10-week trial that evaluates the efficacy and safety of PD 0332334 in subjects ages 18 and older with generalized anxiety disorder.

Study identification

NCT ID
NCT00658762
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 3
Lead sponsor
Pfizer
Industry
Enrollment
286 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 65 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 2008 (Type not available)
Primary completion
Apr 2009 (Actual)
Completion
Apr 2009 (Actual)
Last update posted
Nov 16, 2012

2008 – 2009

United States locations

U.S. sites
27
U.S. states
14
U.S. cities
25
Facility City State ZIP Site status
Pfizer Investigational Site Birmingham Alabama 35226 —
Pfizer Investigational Site Glendale California 91206 —
Pfizer Investigational Site Orange California 92868 —
Pfizer Investigational Site Temecula California 92591 —
Pfizer Investigational Site Upland California 91786 —
Pfizer Investigational Site Wildomar California 92595 —
Pfizer Investigational Site Fort Myers Florida 33912 —
Pfizer Investigational Site Orange City Florida 32763 —
Pfizer Investigational Site Atlanta Georgia 30328 —
Pfizer Investigational Site Marietta Georgia 30060 —
Pfizer Investigational Site Greenwood Indiana 46143 —
Pfizer Investigational Site Wichita Kansas 67207 —
Pfizer Investigational Site Omaha Nebraska 68131 —
Pfizer Investigational Site New York New York 10021-4256 —
Pfizer Investigational Site Syracuse New York 13210 —
Pfizer Investigational Site Beachwood Ohio 44122 —
Pfizer Investigational Site Cincinnati Ohio 45227 —
Pfizer Investigational Site Cleveland Ohio 44109-1998 —
Pfizer Investigational Site Oklahoma City Oklahoma 73103 —
Pfizer Investigational Site Oklahoma City Oklahoma 73116 —
Pfizer Investigational Site Salem Oregon 97301 —
Pfizer Investigational Site Media Pennsylvania 19063 —
Pfizer Investigational Site Norristown Pennsylvania 19401 —
Pfizer Investigational Site Dallas Texas 75231 —
Pfizer Investigational Site Houston Texas 77008 —
Pfizer Investigational Site Houston Texas 77074 —
Pfizer Investigational Site Woodstock Vermont 05091 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00658762, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 16, 2012 · Synced Oct 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00658762 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →